-
-
-
7 . Periodical
A Phase 1, First-in-Human, Dose Escalation and Dose-Expansion Study of a BCMAxCD38xCD3 Targeting Trispecific Antibody ISB 2001 in Subjects with Relapsed/Refractory Multiple Myeloma
- 저자
- by Sia, Hanlon; Menon, Vinu; Garton, Andrew; Wolff, Eileen; Shah, Tejas, et al.
- 소스
- Blood; November 2023, Vol. 142 Issue: 1, Number 1 Supplement 1 p3396-3396, 1p
-
-
7 . Periodical
Dose Escalation of ISB 1342, a Novel CD38xCD3 Bispecific Antibody, in Patients with Relapsed / Refractory Multiple Myeloma (RRMM)
- 저자
- by Kapoor, Prashant; Stevens, Don A.; Leleu, Xavier; Belhadj Merzoug, Karim; Karlin, Lionel, et al.
- 소스
- Blood; November 2023, Vol. 142 Issue: 1, Number 1 Supplement 1 p3339-3339, 1p
-
7 . Periodical
ISB 1442, a First-in-Class CD38 and CD47 Bispecific Antibody Innate Cell Modulator for the Treatment of Relapsed Refractory Multiple Myeloma
- 저자
- by Stefano, Sammicheli; Grandclement, Camille; Dehilly, Elie; Panagopoulou, Maria; Martini, Evangelia, et al.
- 소스
- Blood; November 2021, Vol. 138 Issue: 1, Number 1 Supplement 1 p73-73, 1p